As the obesity treatment program providing free medication ended on June 30, the Health Ministry is seeking a solution to extend it for the 46,000 people who have enrolled.
The program, titled “Prolamvano” (I Prevent), is funded by the Recovery and Resilience Facility. Although it launched in January, patients continued enrolling in the following months.
The program was designed to last six months, but the treatment consists of eight doses. This means that those enrolled still need to receive two additional doses, while all participants have already been notified by email that their appointments have been cancelled.
The program, titled “Prolamvano” (I Prevent), is funded by the Recovery and Resilience Facility. Although it launched in January, patients continued enrolling in the following months.
“At Alexandra Hospital, we have a beneficiary who started treatment just two months ago. In addition, none of the approximately 100 beneficiaries we are monitoring has completed the full eight-dose treatment plan. Unfortunately, unless an announcement is made, they will have to pay for the medication themselves in order to continue their treatment,” Stavroula (Lina) Paschou, Assistant Professor of Endocrinology at the Medical School of the National and Kapodistrian University of Athens and head of the Diabetes Center at Alexandra Hospital, told Kathimerini.
“For the 46,000 beneficiaries currently enrolled, who are entitled to receive up to eight doses because that is what the Joint Ministerial Decision provides for, we will make announcements in the coming days,” Deputy Health Minister Eirini Agapidaki told ERT.
Sources: Καθημερινή, News 247
What is fyi.news?
